查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1786929

胃癌診斷藥市場，規模，佔有率，趨勢，產業分析報告:各產品類型，各疾病類型，各最終用途，各地區 - 市場預測，2025～2034年

Gastric Cancer Diagnostics Market Size, Share, Trends, Industry Analysis Report By Product (Reagents & Consumables, Instruments), By Disease Type, By End Use, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 125 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，全球胃癌診斷市場規模預計到 2034 年將達到 27.8 億美元。本研究報告深入分析了當前的市場動態，並分析了未來的市場成長。

胃癌診斷市場專注於用於檢測和確診胃癌的各種方法和技術。這包括醫療保健專業人員使用的各種醫學檢測、程序和評估，以便及早發現疾病、確定其擴散並制定適當的治療方案。這些診斷方法包括影像學檢查、內視鏡檢查、組織活檢、血液檢測和先進的分子分析，旨在提供準確及時的診斷。

胃癌診斷市場的成長是由全球胃癌病例數量的增加所推動的，這自然促使對診斷服務的需求增加。此外，癌症的早期發現通常可以帶來成功的治療，因此人們越來越重視透過篩檢計畫進行早期發現。該行業也受益於持續的技術進步，這些進步帶來了更新、更準確、侵入性更低的診斷工具，有助於更有效地識別疾病並根據個別患者制定個人化治療方案。

胃癌診斷市場報告重點

按產品劃分，試劑和耗材細分市場預計將在2024年佔最大的市場佔有率，因為試劑和耗材對於幾乎所有診斷測試都至關重要，從常規血液檢測到高級分子分析。

按疾病類型劃分，腺癌是迄今為止最常見的胃癌類型，在2024年佔了最大的市場佔有率。自然而然，大多數診斷工作和資源分配都用於識別和表徵這種廣泛傳播的疾病亞型。

按最終用途劃分，預計醫院領域將在 2024 年佔最大的市場佔有率。醫院是主要的醫療保健機構，患者通常在此接受初步診斷、內視鏡檢查以及綜合診斷基礎設施。

由於北美擁有先進的醫療基礎設施、對早期診斷的高度重視以及對精準醫療的濃厚興趣，預計北美胃癌診斷市場將在 2024 年佔最大佔有率。受全球（尤其是東亞國家）高胃癌發生率的推動，亞太市場正在迅速擴張。

該市場的主要公司包括羅氏公司 (F. Hoffmann-La Roche Ltd.)、雅培實驗室 (Abbott Laboratories)、凱傑公司 (QIAGEN)、伯樂實驗室 (Bio-Rad Laboratories, Inc.)、安捷倫科技公司 (Agilent Technologies, Inc.)、Illumina, Inc., P. Diagnostics、BIOMERIEUX 與 AI Medical Service Inc.

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 全球胃癌診斷市場洞察

  • 市場概述
  • 胃癌診斷市場動態
    • 促進因素和機會
      • 全球胃癌發生率上升
      • 診斷技術的進步
    • 限制因素與挑戰
      • 早期檢測方法有限
  • PESTEL分析
  • 胃癌診斷市場應用趨勢
  • 價值鏈分析
  • COVID-19影響分析

第5章 全球胃癌診斷市場:各產品

  • 主要調查結果
  • 簡介
  • 試劑與消耗品
  • 設備

第6章 全球胃癌診斷市場:各疾病類型

  • 主要調查結果
  • 簡介
  • 腺癌症
  • 胃淋巴瘤
  • 其他

第7章 全球胃癌診斷市場:各最終用途

  • 主要調查結果
  • 簡介
  • 醫院
  • 診斷檢驗室
  • 診斷影像

第8章 全球胃癌診斷市場:地區

  • 主要調查結果
  • 簡介
    • 胃癌診斷市場分析:地區，2020年～2034年
  • 北美
    • 北美:各產品，2020～2034年
    • 北美:各疾病，2020～2034年
    • 北美:各最終用途，2020～2034年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:各產品，2020～2034年
    • 歐洲:各疾病，2020～2034年
    • 歐洲:各最終用途，2020～2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:各產品，2020～2034年
    • 亞太地區:疾病類別，2020～2034年
    • 亞太地區:各最終用途，2020～2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:各產品，2020～2034年
    • 中東·非洲:疾病類別，2020～2034年
    • 中東·非洲:各最終用途，2020～2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲
  • 南美
    • 南美:各產品，2020～2034年
    • 南美:疾病類別，2020-2034年
    • 南美:各最終用途，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第9章 競爭情形

  • 擴大和收購的分析
    • 擴大
    • 收購
  • 聯盟/合作/協定/公開

第10章 企業簡介

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • AI Medical Service Inc.
  • BIOMERIEUX
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • Mirxes Pte. Ltd.
  • Myriad Genetics, Inc.
  • QIAGEN
  • Vela Diagnostics
Product Code: PM5915

The global gastric cancer diagnostics market size is expected to reach USD 2.78 billion by 2034, according to a new study by Polaris Market Research. The report "Gastric Cancer Diagnostics Market Size, Share, Trends, Industry Analysis Report By Product (Reagents & Consumables, Instruments), By Disease Type, By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The gastric cancer diagnostics market focuses on the various methods and technologies used to detect and confirm stomach cancer. This involves a range of medical tests, procedures, and evaluations that healthcare professionals use to identify the disease in its early stages, determine its spread, and guide appropriate treatment plans. These diagnostic approaches include imaging studies, endoscopic examinations, tissue biopsies, blood tests, and advanced molecular analyses, all aimed at providing an accurate and timely diagnosis.

The gastric cancer diagnostics market growth is attributed to the increasing number of gastric cancer cases around the world, which naturally leads to a higher demand for diagnostic services. Additionally, there is a growing emphasis on early detection through screening programs, as finding the cancer early often improves treatment success. The industry is also benefiting from ongoing technological advancements, with newer, more precise, and less invasive diagnostic tools becoming available, which helps identify the disease more effectively and tailoring treatments to individual patients.

Gastric Cancer Diagnostics Market Report Highlights

By product, the reagents & consumables segment held the largest share in 2024 as reagents and consumables are essential for almost every diagnostic test, from routine blood work to advanced molecular analyses.

By disease type, the adenocarcinoma segment held the largest share in 2024, due to its overwhelming prevalence as the most common form of gastric cancer. The majority of diagnostic efforts and resource allocation are naturally directed toward identifying and characterizing this widespread disease type.

By end use, the hospitals segment held the largest share in 2024 as they are the primary healthcare facilities where patients typically receive initial diagnoses, undergo endoscopic procedures, and access comprehensive diagnostic infrastructure.

The North America gastric cancer diagnostics market accounted for the largest share in 2024, due to advanced healthcare infrastructure, high awareness regarding early diagnosis, and a strong focus on precision medicine. The market in Asia Pacific is expanding rapidly, driven by the highest global incidence of gastric cancer, particularly in East Asian countries.

A few key players in the market include F. Hoffmann-La Roche Ltd.; Abbott Laboratories; QIAGEN; Bio-Rad Laboratories, Inc.; Agilent Technologies, Inc.; Illumina, Inc.; Myriad Genetics, Inc.; Mirxes Pte. Ltd.; Vela Diagnostics; BIOMERIEUX; and AI Medical Service Inc.

Polaris Market Research has segmented the gastric cancer diagnostics market report on the basis of product, disease type, end use, and region:

By Product Outlook (Revenue - USD Billion, 2020-2034)

Reagents & Consumables

Instruments

By Disease Type Outlook (Revenue - USD Billion, 2020-2034)

Adenocarcinoma

Gastric lymphoma

Others

By End Use Outlook (Revenue - USD Billion, 2020-2034)

Hospitals

Diagnostic Laboratories

Diagnostic Imaging

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Gastric Cancer Diagnostics Market Insights

  • 4.1. Gastric Cancer Diagnostics Market - Market Snapshot
  • 4.2. Gastric Cancer Diagnostics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Global Incidence of Gastric Cancer
      • 4.2.1.2. Advancements in Diagnostic Technologies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Limited early detection methods
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Gastric Cancer Diagnostics Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Gastric Cancer Diagnostics Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • 5.3. Reagents & Consumables
    • 5.3.1. Global Gastric Cancer Diagnostics Market, by Reagents & Consumables, by Region, 2020-2034 (USD Billion)
  • 5.4. Instruments
    • 5.4.1. Global Gastric Cancer Diagnostics Market, by Instruments, by Region, 2020-2034 (USD Billion)

6. Global Gastric Cancer Diagnostics Market, by Disease Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • 6.3. Adenocarcinoma
    • 6.3.1. Global Gastric Cancer Diagnostics Market, by Adenocarcinoma, by Region, 2020-2034 (USD Billion)
  • 6.4. Gastric lymphoma
    • 6.4.1. Global Gastric Cancer Diagnostics Market, by Gastric lymphoma, by Region, 2020-2034 (USD Billion)
  • 6.5. Others
    • 6.5.1. Global Gastric Cancer Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Gastric Cancer Diagnostics Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Global Gastric Cancer Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)
  • 7.4. Diagnostic Laboratories
    • 7.4.1. Global Gastric Cancer Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)
  • 7.5. Diagnostic Imaging
    • 7.5.1. Global Gastric Cancer Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Gastric Cancer Diagnostics Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Gastric Cancer Diagnostics Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Gastric Cancer Diagnostics Market - North America
    • 8.3.1. North America: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
    • 8.3.2. North America: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
    • 8.3.3. North America: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.3.4. Gastric Cancer Diagnostics Market - U.S.
      • 8.3.4.1. U.S.: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.3.5. Gastric Cancer Diagnostics Market - Canada
      • 8.3.5.1. Canada: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • 8.4. Gastric Cancer Diagnostics Market - Europe
    • 8.4.1. Europe: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.4. Gastric Cancer Diagnostics Market - UK
      • 8.4.4.1. UK: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.5. Gastric Cancer Diagnostics Market - France
      • 8.4.5.1. France: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.6. Gastric Cancer Diagnostics Market - Germany
      • 8.4.6.1. Germany: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.7. Gastric Cancer Diagnostics Market - Italy
      • 8.4.7.1. Italy: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.8. Gastric Cancer Diagnostics Market - Spain
      • 8.4.8.1. Spain: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.9. Gastric Cancer Diagnostics Market - Netherlands
      • 8.4.9.1. Netherlands: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.10. Gastric Cancer Diagnostics Market - Russia
      • 8.4.10.1. Russia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.11. Gastric Cancer Diagnostics Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • 8.5. Gastric Cancer Diagnostics Market - Asia Pacific
    • 8.5.1. Asia Pacific: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.4. Gastric Cancer Diagnostics Market - China
      • 8.5.4.1. China: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.5. Gastric Cancer Diagnostics Market - India
      • 8.5.5.1. India: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.6. Gastric Cancer Diagnostics Market - Malaysia
      • 8.5.6.1. Malaysia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.7. Gastric Cancer Diagnostics Market - Japan
      • 8.5.7.1. Japan: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.8. Gastric Cancer Diagnostics Market - Indonesia
      • 8.5.8.1. Indonesia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.9. Gastric Cancer Diagnostics Market - South Korea
      • 8.5.9.1. South Korea: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.10. Gastric Cancer Diagnostics Market - Australia
      • 8.5.10.1. Australia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.11. Gastric Cancer Diagnostics Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • 8.6. Gastric Cancer Diagnostics Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.4. Gastric Cancer Diagnostics Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.5. Gastric Cancer Diagnostics Market - UAE
      • 8.6.5.1. UAE: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.6. Gastric Cancer Diagnostics Market - Israel
      • 8.6.6.1. Israel: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.7. Gastric Cancer Diagnostics Market - South Africa
      • 8.6.7.1. South Africa: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.8. Gastric Cancer Diagnostics Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • 8.7. Gastric Cancer Diagnostics Market - Latin America
    • 8.7.1. Latin America: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.4. Gastric Cancer Diagnostics Market - Mexico
      • 8.7.4.1. Mexico: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.5. Gastric Cancer Diagnostics Market - Brazil
      • 8.7.5.1. Brazil: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.6. Gastric Cancer Diagnostics Market - Argentina
      • 8.7.6.1. Argentina: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.7. Gastric Cancer Diagnostics Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott Laboratories
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Agilent Technologies, Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. AI Medical Service Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. BIOMERIEUX
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Bio-Rad Laboratories, Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. F. Hoffmann-La Roche Ltd
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Illumina, Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Mirxes Pte. Ltd.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Myriad Genetics, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. QIAGEN
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Vela Diagnostics
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development

List of Tables:

  • Table 1 Global Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 2 Global Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 3 Global Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 4 North America: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 5 North America: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 6 North America: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 7 U.S.: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 8 U.S.: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 9 U.S.: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 10 Canada: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 11 Canada: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 12 Canada: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 13 Europe: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 14 Europe: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 15 Europe: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 16 UK: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 17 UK: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 18 UK: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 19 France: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 20 France: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 21 France: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 22 Germany: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 23 Germany: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 24 Germany: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 25 Italy: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 26 Italy: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 27 Italy: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 28 Spain: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 29 Spain: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 30 Spain: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 34 Russia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 35 Russia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 36 Russia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 43 China: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 44 China: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 45 China: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 46 India: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 47 India: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 48 India: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 52 Japan: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 53 Japan: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 54 Japan: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 58 South Korea: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 59 South Korea: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 60 South Korea: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 61 Australia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 62 Australia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 63 Australia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 73 UAE: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 74 UAE: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 75 UAE: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 76 Israel: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 77 Israel: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 78 Israel: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 79 South Africa: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 80 South Africa: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 81 South Africa: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 85 Latin America: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 86 Latin America: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 87 Latin America: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 88 Mexico: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 89 Mexico: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 90 Mexico: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 91 Brazil: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 92 Brazil: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 93 Brazil: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 94 Argentina: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 95 Argentina: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 96 Argentina: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Gastric Cancer Diagnostics Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Gastric Cancer Diagnostics Market, by Product, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Disease Type
  • Figure 9. Global Gastric Cancer Diagnostics Market, by Disease Type, 2024 & 2034 (USD Billion)
  • Figure 10. Market by End Use
  • Figure 11. Global Gastric Cancer Diagnostics Market, by End Use, 2024 & 2034 (USD Billion)